+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

Spinal Cord Trauma Treatment - Global Strategic Business Report - Product Thumbnail Image

Spinal Cord Trauma Treatment - Global Strategic Business Report

  • Report
  • September 2026
  • 218 Pages
  • Global
From
From
From
From
Moderate To Severe Inflammatory Acne Vulgaris- Pipeline Insight, 2025 - Product Thumbnail Image

Moderate To Severe Inflammatory Acne Vulgaris- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Halothane Market - Global Forecast to 2030 - Product Thumbnail Image

Halothane Market - Global Forecast to 2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Esters Anesthetic Market - Global Forecast to 2030 - Product Thumbnail Image

Esters Anesthetic Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Acute Spinal Cord Injury Market - Global Strategic Business Report - Product Thumbnail Image

Acute Spinal Cord Injury Market - Global Strategic Business Report

  • Report
  • September 2026
  • 274 Pages
  • Global
From
Acute Dystonia Market - Global Strategic Business Report - Product Thumbnail Image

Acute Dystonia Market - Global Strategic Business Report

  • Report
  • September 2026
  • 372 Pages
  • Global
From
Dermatological Drugs - Global Strategic Business Report - Product Thumbnail Image

Dermatological Drugs - Global Strategic Business Report

  • Report
  • September 2026
  • 422 Pages
  • Global
From
EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)- Pipeline Insight, 2025 - Product Thumbnail Image

EGFR Non-Small Cell Lung Cancer (EGFR + NSCLC)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Loading Indicator